Skip to main content
. 2017 Jan 19;8(9):14988–14994. doi: 10.18632/oncotarget.14744

Table 3. Survival analysis for recurrence-free survival.

Variables Category Recurrence-free survival in all patients
Univariate analysis Multivariate analysis
P P HR 95% CI
Age, years < 64 vs ≥ 64 0.666 0.097 5.209 0.743–36.514
pTNM Stage I & II vs. III 0.030 0.050 6.630 0.999–44.012
miR-BART20-5p High vs. low 0.016 0.034 6.951 1.158–41.737

pTNM, pathologic tumor-node-metastasis.